Public and patient involvement (PPI) at King’s: Community for Research Involvement and Support for people with Parkinson’s (CRISP)

Posted in Special Feature on 6th Oct 2016

 

mubasherMubasher A Qamar is a clinical researcher at King’s College Hospital, Centre of Parkinson’s Excellence, working with Professor Ray Chaudhuri’s team since January 2016. Mubasher has completed his Masters in Neuroscience.  He has been a research administrator for many of the projects at King’s including being involved in active clinical trials and also developing research websites. His research data on non-motor aspects of Parkinson’s was presented at the recent movement disorders society international congress MDS2016, world Parkinson’s congress WPC 2016 and NMDPD2016. He has also published several review papers on Parkinson’s.

alex-rizos-webAlexandra Rizos trained as a scientist in human biology in Marburg, Germany and works since 2011 as European Research Manager for EUROPAR, a group of academics dedicated to non-motor aspects of Parkinson’s, delivering excellence in clinical research across Europe. Alexandra is based at the National Parkinson’s Foundation centre of excellence at Kings College Hospital, London and has an international role as the co-ordinator of the IPMDS non motor PD study group.

Alexandra also manages research on behalf of the London South Nervous Systems sub-speciality group across the UK and is leading CRISP (Community for Research Involvement and Support for people with Parkinson’s), a patient and public involvement group at King’s.

liba-stones-webLiba Stones gained an MA in Anthropology and Indonesian Studies at Charles University in Prague in 2003 and an MBA at the Open University in 2013. Liba started her career in NHS management in Cumbria where she held various project management posts and set up the first clinical research team and research portfolio in mental health and community services. Liba subsequently held Research Manager posts at Barnet and Chase Farm Hospitals and Royal Free Hospital. Since 2015 she has worked as Research & Innovation Manager at Kings College Hospital where she runs the clinical research operation in one of the UK’s largest and most research active NHS teaching Trusts.

claire-meachinClare Meachin is Deputy Chief Operating Officer for CRN South London and has worked with the Clinical Research Network since 2006. Clare has many years of both clinical and research experience.

Clare originally trained as a Registered Nurse at Barts Health NHS Trust. She has worked in Neurology & Neurosurgery and General Medicine and spent 4 years in Nigeria running a Leprosy Hospital and a Motherless Babies Home. Her interest in research began following three years working with injecting drug users on the streets of Oxford and a funded project to look at the incidence of mental illness in the homeless population. She has also worked as Lead Research Nurse managing a research team of 50 across all specialties and alongside this studied for an MSc in Clinical Education. More recently Clare has worked as an R&D Manager before moving to her current role as Deputy Chief Operating Officer.

ray-chaudhri-webK Ray Chaudhuri is Professor in Neurology/Movement Disorders and Consultant Neurologist at King’s College Hospital and King’s College, London, and Institute of Psychiatry, Psychology and Neuroscience, London, an Academic Health Sciences Centre, and also principal investigator at the MRC centre for neurodegeneration research at King’s College, London.

He is the Medical Director of the National Parkinson Foundation International Centre of Excellence at King’s College, London. He sits on the Nervous Systems Committee of UK Department of Health, National Institute of Health Research and also serves as co-chairman of the appointments/liaison committee of the International Parkinson and Movement Disorder Society (IPMDS) and is currently serving as the member of the scientific programme committee of the IPMDS. He is the Chairman of the IPMDS Parkinson’s disease (PD) non-motor study group. He serves on the task force of practice parameter group for PD and restless legs syndrome (RLS) and more recently Non-Motor Symptoms of Parkinson’s, American Academy Neurology. He is the Editor in Chief of Nature Parkinson’s disease journal and the European Editor of Basal Ganglia and is in the editorial board of Parkinsonism and Related Disorders and Journal of Parkinson’s Disease.

Correspondence to: Mubasher A Qamar, Kings College Hospital, London. E. mubasher.qamar@kcl.ac.uk
Conflict of interest statement:
Provenance and peer review: Submitted and externally reviewed.
To cite: ACNR 2016; 16(3)
First published online:
6/10/16


Introduction

The concept of patient and public involvement (PPI) in healthcare has been around since 1974, however it has been a struggle for it to be effectively implemented and supported,1 as evident by several organisations set up and abolished over time (table 1 below).2 Specific to health research, PPI has recently become a popular notion and as such is the standard expectation by most government funded health research. The need to increasingly hold researchers to account, recognise barriers in knowledge and research, and occasionally, the unrealistic expectations, have dominated research regulations.3,4 Therefore, there has been a growing requirement to give patients and the public the ability to contribute and shape research.5,6 This increase in PPI allows for greater quality reassurance and provides the certainty that the research being conducted will be beneficial for making the concept of bench-to-bedside a reality.7,8


Table 1: Brief summary of PPI set up in NHS (England)

1974    Community Health Councils (CHCs) set up

2000     Overview and Scrutiny Committee set up

2002    CHCs abolished

2003     Commission for Patient and Public Involvement in Health (CPPIH)

2003    Patient Advice and Liaison Service (PALS), Independent Complaints Advocacy Service (ICAS), and Patient and Public Involvement Forums (PPIfs) set up

2004    CPPIH abolished

2006    PPIfs abolished

2006   Local Involvement Networks (LINks) set up

2013    LINks abolished

2013    Healthwatch England set up


The Health Research Authority (HRA) in the UK conducted a survey on public attitude towards medical research in which they found patient’s would have greater confidence in research if they had counselled the design and implementation of the research study.9 Many patients are well equipped with understanding their own condition through experience, sometimes, better than the clinicians and researchers. Therefore, their ambitions and viewpoints may not have been considered by those conceptualizing research for their condition. By having PPI in active partnership with the researchers and clinicians, a unified research design is achieved which is likely to have beneficial effects to patients and the National Health Service (NHS). This is echoed by the Research Ethics Committee (REC) who are often concerned by the patient specific aspects such as consent, recruitment and information quality, much of which can be addressed by a PPI group.10 A few core fundamental aspects of having a PPI in research are that it will help:11,12

  1. Corroborate the relevance of the project to the patients;
  2. Improve the basic research question;
  3. Identify appropriate research methodologies;
  4. Understand the potential outcomes for patients;
  5. Achieve greater understanding of how to enable the research to deliver to time and target (i.e. recruiting patients in research period).

NIHR Initiatives

The National Institute of Health Research (NIHR) work to provide support and guidance to researchers in various ways to deliver practical research, which work to make patients and the NHS better.13 One of the aims of NIHR is to empower patients and the public to participate and shape research,14 hence, they fund an advisory group, INVOLVE. This group is one-of-a-kind in the world, and works to collate expertise and experiences in research through increasing public involvement.15 INVOLVE are defined as a group aiming for research to be carried out ‘with’ or ‘by’ the public rather than research ‘to’, ‘about’ or ‘for’ the public.16 The NIHR has set out various PPI guidelines with the aim to ensure researchers involve the public in their studies as much as possible, hence safeguarding the practicality of the research outcome. As a result, INVOLVE sets out detailed guidelines for researchers to follow ensuring the successful achievement of PPI.16

…attending these meetings allows me to hear a patients prospective and experience of my clinics which is very helpful as I can then go back and make appropriate changes to further help my patients…Miriam Parry (Specialist PD nurse, CRISP)

The importance of PPI in research is evident in all stages of submitting project proposals and up to the final report. This is echoed by the NIHR Evaluation, Trials and Studies Coordinating Center (NETSCC), which manage the NIHR, Evaluation, Trials and Studies (NETS) programs, who expect there to be active PPI in any research they fund and support.17

What is the impact of PPI?

A review into the impact of PPI has been undertaken by Staley (2009) who reported to find there being a significant effect on the identification of the research question to the designing and delivering of the project.18 Staley also finds early involvement to be beneficial for cost and ethical difficulties which may later arise. Their review highlights that the impact of PPI has no robust method of evaluation. Nonetheless, the general opinion is that PPI has a positive impact on research in almost all aspects. Brett and colleagues (2014) conducted a review of the impact PPI have on research whereby they found PPI helped identify researcher’s limitation in knowledge, which equipped them to then develop to resolve these problems. Alongside these practical benefits of having PPI, they have also been shown to have financial benefits by helping to prevent potential losses through helping refine and identifying pitfalls in projects during the design stage.6,19,20 Several studies have shown successful design and implementation of research, following PPI group advice, which provided vital information to conduct successful research.21-27 INVOLVE, along with the Mental Health Research Network (MHRN) and the School for Primary Care Research, commissioned case studies looking at research and PPI,28-32 and found a significant positive impact of PPI.

Whilst PPI is certainly not a new model, as evident by mental health research utilizing PPI involvement for decades now, it is not as well-established in all specialties. Neurodegenerative conditions, such as Parkinson’s disease (PD), are set to rise 28% by 202033 creating a substantial need to perpetuate research in this field. Hence, the need for robust PD PPI has been an unmet need for some time, however, this is now changing.

Local Initiative at King’s translating to a national project

King’s College Hospital (King’s) Parkinson’s center led the development of the ‘King’s PPI group’, which consisted of a range of public representatives (patients, carers) and NHS trust staff (researchers, health professionals) as well as representation from key PD patient charities (see picture 1). The original members of King’s PPI, where approached following a movement disorder multidisciplinary team meeting at the trust. Potential patients where asked if they would like to be involved, subsequently, on accepting, they were sent a formal letter of invitation. Since this initial recruitment, leaflets and informative posters have been created and placed in clinics to help encourage patients and the public to participate in research.

This group later renamed itself as CRISP (Community for Research Involvement and Support for people with Parkinson’s). Furthermore, the logo for CRISP itself was designed by one of the Patients with Parkinson’s (PwP) representatives. CRISP was created to incorporate the requirements and guidance from the NIHR regarding conducting successful and meaningful research for PD patients and carers. It therefore runs in line with INVOLVE guidelines and is supported by several other research organizations including EUROPAR (European network for Parkinson’s), Parkinson’s UK and London South CRN (Clinical Research Network).34 The concept behind this group is underpinned by the fact that they work to contribute towards the design and development of research projects in accordance with patient and caregiver opinions and needs.34

figure

FIGURE 1: CRISP follows the principles set by INVOLVE. INVOLVE is funded and run by the NIHR. CRISP works closely with EUROPAR (a non-profit multi-displinary organisation with key opinion leaders working to improve Parkinson’s related clinical research), Parkinson’s UK (a supportive research charity), members of the CRN sit in CRISP as representatives, and the EPDA supports the overall aims of CRISP. CRISP, Community for Research Involvement and Support for people with Parkinson’s; EUROPAR; EUROpean Network for PARkinson’s Disease; UK, United Kingdom; CRN, Clinical Research Network; EPDA, European Parkinson’s Disease Association.

 

What are the aims of CRISP?

CRISP is based at King’s College Hospital in South London and predominately deals with Parkinson’s based research. They meet with representatives from each group working to discuss (a) the design, development and practicality of research projects, (b) discussing and reviewing current research, (c) gathering patient and public opinions on proposed projects and (d) generating novel concepts for research the group feels needs to be undertaken.34 The primary aims of CRISP can be summarized into two categories; research initiatives and raising research awareness. See figure 2 for a diagrammatic representation of CRISP aims, with a few examples.

picture-1

CRISP meeting Left to right: Eros Bresolin (PwP), David Charlton (PwP), Alexandra Rizos (EUROPAR European Research manager), Lauren Perkins (Senior research coordinator), K Ray Chaudhuri (Prof of Movement Disorders at King’s), Miriam Parry (Specialist PD nurse), Theresa Chiwera (Research nurse), Stephen Roberts (PwP), Rosalind Roberts (carer of PwP), and Flora Hill (carer of PwP).

figure-2

Figure 2: CRISP main two aims; Parkinson’s research and raising patient participation awareness PD, Parkinson’s Disease; RS, research study; NMS, non-motor symptoms; CRISP, Community for Research Involvement and Support for People with Parkinson’s; Stat, simvastatin.

 

CRISP & Research

The members of CRISP typically meet on a quarterly basis with each meeting lasting around 2 hours. During a meeting, researchers provide a printed list of all ongoing and proposed projects at the Trust sites. Each project synopsis is provided and discussed with the CRISP members, enabling an atmosphere whereby both researchers and members can ask questions. This form of discussion has proven to be very useful in the past. For example, one project requiring patients to attend clinic in ‘off’ state would need to consider how difficult it would be for a patient to arrive to the clinic in that state, hence suggestions of staying overnight at the hospital or local hotel would be more practical and achievable. With some urgent progress on new and upcoming projects arising throughout the year, the members are all reachable via email or post if their involvement is particularly useful and required prior to an upcoming meeting.

Research groups in Parkinson’s, such as EUROPAR, have utilized CRISP by involving the members to participate and review new editions of patient-friendly books (i.e. the ‘Fast Facts in PD: 4th edition’) and helped the fine-tuning of inclusion criteria for some research projects (i.e. PD simvastatin clinical trial) prior to submission for approval. 35 This type of collaborative work has led to many successful identification and changes in the NHS and work worldwide, with regards to the way we approach Parkinson’s patient care. One success story of a CRISP-led project has been the development of the King’s Parkinson’s disease Pain Scale (King’s PD Pain Scale), which is now a validated scale.36 See figure 3 for the outline of how CRISP was involved in the making of this scale.

figure-3

Figure 3: Flow-chart representing CRISP involvement in developing the King’s Parkinson’s Disease Pain Scale (King’s PD Pain Scale). During CRISP meetings and prior research, the issue with the inability to identify and help PD patients with pain was recognized as an underdeveloped problem. The researchers developed a novel PD Pain Scale, the validation study of which was then funded by Parkinson’s UK, who requested a patient completed questionnaire (King’s PD Pain Quest) to be added to the study, to empower patients to self-declare their pain. The success of the King’s PD Pain Scale has led it to be recognized worldwide and be validated as a clinical tool capable of being used to help PD patients and clinicians in managing pain in PD. KRC, Professor K Ray Chaudhuri; PD, Parkinson’s disease; CRISP, Community for Research Involvement and Support for People with Parkinson’s.

 

CRISP & Patient awareness video

It is essential to appreciate the difference between the involvement and participation, whereby patient involvement is achieved through PwP represented in CRISP, whilst patient participation is the active partaking in clinical research. CRISP works to promote both aspects through various means (i.e. leaflets, videos).

… there are academics who devote their whole career to understanding a small part of the puzzle, […] e.g. Parkinson’s. If I can be part of that processes, then my future with [PD] looks more positive and the future of my three children without PD looks more certain… Suzanne Pitts (PwP, CRISP)

For research to be beneficial in the real world for patients, it must be trialed and tested to ensure it works. However, due to lack of public awareness and misunderstanding as to what might be expected from the patient, this leads many researchers to have patient recruitment problems.37 This has been addressed by CRISP through the development of a video whereby CRISP members speak about their experience with active and advisory PPI. This video has now become a regular feature on the NIHR TV (https://www.youtube.com/watch?v=jERbtxASRAI), as well as being displayed in the clinical waiting rooms for patients. Along with the video, there has been a range of positive material such as flyers and letters by CRISP to raise awareness for research in the public.

CRISP is a good representation of everyone involved in PD… it has helped us understand how research works and the steps involved. It allows for more appreciation of the work done and what needs to be done… Eros Bresolin (PwP, CRISP)

By creating these promotional materials, CRISP has worked to help achieve goals set by research organizations. The NIHR and INVOLVE, both work to promote a multi-disciplinary approach to research whereby clinicians, researchers and senior academics should have PPI implemented in every step of the project. CRISP, since 2011, has established an essential role in fulfilling NIHR, and further the HRA, expectations of an Excellent Research Centre. This has been achieved through the identification of problems that Parkinson’s patients experience and allow research to be tailored to ensure the actual problems are being addressed.

modern treatments for Parkinson’s only became available after research and testing on [PD] patients. Seems only fair, therefore, that I make my own contribution you never know, research may lead to treatment beneficial to me…David Charlton (PwP, CRISP)

Future of PPI

Depending on the funder, PPI is becoming a mandatory condition on many applications for researchers. Furthermore, dedicated toolkits and frameworks are now set-up (i.e. Public Involvement Impact Assessment Framework (PiiAF) to aid in assessing PPI impact on projects. However, some funding bodies still do not set PPI as a mandatory requirement, moreover funding for PPI is currently limited. Movement disorder specific PPI are still sparse, and following the success and achievements of CRISP, it is necessary to establish specific PPI in each research center in the UK. This will address the need to improve patient and public knowledge about research participation and involvement.

Acknowledgements:

We would like to thank the members of CRISP for their time and contribution towards making this article: Eros Bresolin, David Charlton, Lauren Perkins, Miriam Parry, Theresa Chiwera, Dhaval Trivedi, Foster Murphy, Suzanne Pitts, Sally Anne Olivier, Tomas Gisby, Stephen Roberts, Rosalind Roberts, Flora Hill and Sheamus Olivier.

REFERENCES:

  1. Hogg CNL. Patient and public involvement: What next for the NHS? Health Expectations. 2007;10(2):129-138.
  2. Committee, H.o.C.H. Patient and Public Involvement in the NHS, 3rd report. H.o. Commons, Editor. 2007.
  3. Kelman CW, Bass AJ, Holman CDJ. Research use of linked health data — a best practice protocol. Australian and New Zealand Journal of Public Health. 2002; 26(3):251-255.
  4. Boaz A, Biri D, McKevitt C. Rethinking the relationship between science and society: Has there been a shift in attitudes to Patient and Public Involvement and Public Engagement in Science in the United Kingdom? Health Expectations. 2016; 19(3):592-601.
  5. Bastian, H. The Power of Sharing Knowledge. Consumer participation in the Cochrane Collaboration. UK Cochrane Centre, 1994.
  6. Boote J, Telford R, Cooper C. Consumer involvement in health research: a review and research agenda. Health Policy. 2002;61(2):213-236.
  7. Entwistle VA, et al. Lay perspectives: advantages for health research. BMJ, 1998;316(7129):463-466.
  8. Chalmers I. What do I want from health research and researchers when I am a patient? BMJ. 1995;310(6990):1315-1318.
  9. HRA N. Patient involvement increases public confidence in health research. News 2013 [cited 2016; Available from: http://www.hra.nhs.uk/news/2013/11/22/patient-involvement-increases-public-confidence-health-research/.
  10. INVOLVE. Impact of public involvement on the ethical aspects of research. H.R. Authority, Editor. 2016.
  11. INVOLVE, Patient and public involvement in research and research ethics committee review INVOLVE, 2009.
  12. INVOLVE, Public involvement in research and research ethics committee review, H.R. Authority, Editor. 2016. p. 4.
  13. NIHR. Five year strategic plan for research delivery: 2012-2017. NIHR Clinical Research Network 2012; Available from: https://www.crn.nihr.ac.uk/wp-content/uploads/About%20the%20CRN/CRN%20Strategic%20Plan%202012-17.pdf.
  14. NIHR. Vision/ Mission/ Aims. 2015; Available from: http://www.nihr.ac.uk/about/mission-of-the-nihr.htm.
  15. INVOLVE. About INVOLVE. 2015 [cited 2016; Available from: http://www.invo.org.uk/about-involve/.
  16. INVOLVE, Briefing notes for researchers: public involvement in NHS, public health and social care research. 2012.
  17. NIHR. Public Involvement in your research. 2016; Available from: http://www.nihr.ac.uk/funding/public-involvement-in-your-research.htm.
  18. Staley K. Exploring Impact: Public involvement in NHS, public health and social care research (INVOLVE). NIHR. 2009:116.
  19. Brett J, et al. A Systematic Review of the Impact of Patient and Public Involvement on Service Users, Researchers and Communities. The Patient – Patient-Centered Outcomes Research. 2014.;7(4):387-395.
  20. Shippee ND, et al. Patient and service user engagement in research: a systematic review and synthesized framework. Health Expectations. 2015;18(5):1151-1166.
  21. Holm KE, et al. Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPD. The Patient – Patient-Centered Outcomes Research. 2016; 9(3):271-279.
  22. de Wit M. Patient Participation in Rheymatology Research: a four level response evaluation. 2013, University of Bristol.
  23. Howe A, et al. Public involvement in health research: a case study of one NHS project over 5 years. Health Care Research & Development. 2010;11(1):17-28.
  24. Pohontsch NJ, et al. The professional perspective on patient involvement in the development of quality indicators: a qualitative analysis using the example of chronic heart failure in the German health care setting. Patient Prefer Adherence. 2015;9:151-9.
  25. Bray, L, Collier S. Research essentials: Developing and designing research through consultation and collaboration with children and young people. Nursing Children and Young People. 2016;28(4):12.
  26. Kreindler, SA, Struthers A. Assessing the organizational impact of patient involvement: a first STEPP. Int J Health Care Qual Assur. 2016;29(4):441-53.
  27. Hyde C, et al. Process and impact of patient involvement in a systematic review of shared decision making in primary care consultations. Health Expect, 2016.
  28. Pinfold V, et al. Putting lay voices into primary care research : PPI strategies and early steps in the PARTNERS2 study, in School for Primary Care Research conference. 2014, NIHR.
  29. Robens S. Improving Physical Health and Reducing Substance Use in Severe Mental Illness (IMPaCT) A case study on carer involvement in mental health research. 2013, NIHR.
  30. Robinson L. Supporting Excellence in End of life care in Dementia – SEED programme. INVOLVE NIHR, 2013.
  31. Staley K. The Super EDEN Programme – A case study illustrating the impact of service user and carer involvement. NIHR, 2013.
  32. Staley K. The PRIMROSE programme – A case study illustrating the impact of service user and carer involvement. 2013, NIHR.
  33. UK, P.s. Number of people with Parkinson’s in the UK is set to rise. 2012; Available from: http://www.parkinsons.org.uk/news/23-january-2012/number-people-parkinsons-uk-set-rise.
  34. CRISP, CRISP: Terms of reference. 2015, parkinsons-london.co.uk.
  35. CRISP, CRISP – EUROPAR Patient Group Meeting, T. Chiwera, Editor. 2015.
  36. Chaudhuri KR, et al. King’s Parkinson’s disease pain scale, the first scale for pain in PD: An international validation. Mov Disord. 2015;30(12):1623-31.
  37. Chew-Graham, C. Positive reporting? Is there a bias is reporting of patient and public involvement and engagement? Health Expectations. 2016;19(3):499-500.
Download this Article
SIGN UP FOR OUR MAILING LIST

Open Access, for medical professionals: Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified. 

We may infrequently send you news from our sponsors which is relevant to the field of neurology, but you can opt out at any time.

See a sample email newsletter here
This website is for medical professionals only.